Recent Reports


Evidence report on cystic fibrosis. Due to the COVID-19 pandemic, the public meeting to discuss this report has been postponed. 

View More on this Topic


Evidence report on sickle cell disease. This report will serve as the basis for discussion during a public meeting of the New England CEPAC on March 26, 2020.

View More on this Topic

ICER’s final report on acute migraine treatments, including a summary of the public meeting and key policy recommendations.  

View More on this Topic

Materials

Alternative Pricing Models for Remdesivir and Other Potential Treatments for COVID-19

New England CEPAC

Hemophilia A: Evidence Presentation

New England CEPAC

Supervised Injection Facilities: Draft Scoping Document

New England CEPAC

Supervised Injection Facilities: Stakeholder List

New England CEPAC

Supervised Injection Facilities: Open Input

Midwest CEPAC

Bladder Cancer: Open Input

Midwest CEPAC

Digital Apps for OUD: Open Input

Midwest CEPAC

Bladder Cancer: Stakeholder List

Midwest CEPAC

Bladder Cancer: Draft Scoping Document

Midwest CEPAC

Digital Apps for OUD: Stakeholder List

Midwest CEPAC

Digital Apps for OUD: Draft Scoping Document

Midwest CEPAC

Acute Migraine: Policy Recommendations